| Page 2095 | Kisaco Research
 

Shanrong Zhao

Director, Computational Biology and Bioinformatics,Pfizer Worldwide Research & Development
Pfizer

Shanrong Zhao

Director, Computational Biology and Bioinformatics,Pfizer Worldwide Research & Development
Pfizer

Shanrong Zhao

Director, Computational Biology and Bioinformatics,Pfizer Worldwide Research & Development
Pfizer
 

John Baldoni

Senior Vice President, In silico Drug Discovery
GlaxoSmithKline

John Baldoni

Senior Vice President, In silico Drug Discovery
GlaxoSmithKline

John Baldoni

Senior Vice President, In silico Drug Discovery
GlaxoSmithKline
 

Olivier Guenat

Head of Organs-on-Chip Technologies, ARTORG Center for Biomedical Engineering Research
University of Bern-Switzerland

Olivier Guenat

Head of Organs-on-Chip Technologies, ARTORG Center for Biomedical Engineering Research
University of Bern-Switzerland

Olivier Guenat

Head of Organs-on-Chip Technologies, ARTORG Center for Biomedical Engineering Research
University of Bern-Switzerland
 

Adrian Britschgi

Lab Head MTT Discovery Oncology
Roche

Adrian Britschgi

Lab Head MTT Discovery Oncology
Roche

Adrian Britschgi

Lab Head MTT Discovery Oncology
Roche
 

Josep Samitier

Director
Institute for Bioengineering of Catalonia

Josep Samitier

Director
Institute for Bioengineering of Catalonia

Josep Samitier

Director
Institute for Bioengineering of Catalonia
 

Philip Hewitt

Global Head of early Non Clinical Safety (Liver and Kidney)
Merck KGaA

Philip Hewitt

Global Head of early Non Clinical Safety (Liver and Kidney)
Merck KGaA

Philip Hewitt

Global Head of early Non Clinical Safety (Liver and Kidney)
Merck KGaA
 

Magnus Ingelman-Sundberg

Karolinska Institutet

Magnus Ingelman-Sundberg

Karolinska Institutet

Magnus Ingelman-Sundberg

Karolinska Institutet
 

Professor Paul Gatenholm

Chemistry and Chemical Engineering
Biopolymer Technology

Professor Paul Gatenholm

Chemistry and Chemical Engineering
Biopolymer Technology

Professor Paul Gatenholm

Chemistry and Chemical Engineering
Biopolymer Technology
 

Robert Vries

Managing Director
Hubrecht Organoid Technology

Robert Vries

Managing Director
Hubrecht Organoid Technology

Robert Vries

Managing Director
Hubrecht Organoid Technology
 

Tommy Andersson

Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit
AstraZeneca R&D Mölndal

Tommy Andersson

Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit
AstraZeneca R&D Mölndal

Tommy Andersson

Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit
AstraZeneca R&D Mölndal